Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-19-000620
Filing Date
2019-05-29
Accepted
2019-05-29 17:08:29
Documents
2
Period of Report
2019-05-29

Document Format Files

Seq Description Document Type Size
1 form4-05292019_020516.html 4  
1 form4-05292019_020516.xml 4 4109
2 ex24-05292019_020516.htm EX-24 6596
  Complete submission text file 0001415889-19-000620.txt   12321
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

EIN.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 12 MIKHA'EL NE'EMAN ST TEL AVIV-YAFO L3 6958101
Business Address
Veinrib Gadi (Reporting) CIK: 0001726015 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 19863021